Albert Regis
Story Poster
Jacksonville Jaguars select Albert Regis in the third round, 81st overall
11 days ago by Olin Buchanan
Texas A&M defensive tackle Albert Regis was selected in the third round, 81st overall, by the Jacksonville Jaguars in the 2026 NFL Draft on Friday. In 49 career games as an Aggie, Regis accumulated 116 total tackles, 11 TFLs and 3.5 sacks.
Story Poster
3:56
Setting the Scene: 13 Aggies ready to impress at 2026 NFL Combine
2 mo ago by David Nuño
Players will begin making their rounds at the 2026 NFL Scouting Combine on Wednesday, and Texas A&M leads the country with 13 invitees to Indianapolis. Before the Aggies start making the rounds, David Nuño and Olin Buchanan discuss what they're excited to see this week.
Story Poster
5:10
Stephen McGee offers thoughts on A&M's rise in NFL-caliber talent
2 mo ago by David Nuño
Texas A&M will send a school-record 13 Aggies to the 2026 NFL Combine. Former A&M QB Stephen McGee joins Thursday's edition of TexAgs Live to speak on the Ags headed to the next level, Mike Elko's development of players and much more.
Get access to all Premium content today
Start your subscription for just $1
Try Premium Now
Story Poster
6:53
Lunch with Liucci: Billy Liucci joins TexAgs Live (Friday, February 6)
2 mo ago by Billy Liucci
TexAgs' co-owner and executive editor Billy Liucci joined TexAgs Live on Friday morning to talk Texas A&M basketball ahead of Saturday night's blackout game against Florida at Reed Arena. Looch also discussed Elko's 2026 Aggies, Charles Bediako's situation and Sunday's Super Bowl LX.
Story Poster
5:52
Lunch with Liucci: Billy Liucci joins TexAgs Live (Friday, January 30)
3 mo ago by Billy Liucci
TexAgs' co-owner and executive editor Billy Liucci joined TexAgs Live on Friday morning to talk Texas A&M basketball's hot start to conference play with Georgia up next. Liucci also discusses the Aggies that could be taken in the NFL Draft's first round and more.
 
×
subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.